Lymphatic filariasis, commonly known as elephantiasis, is caused by thread-like parasitic worms transmitted by mosquitoes. The infection can silently damage the lymphatic system for years before triggering the grotesque limb swelling and genital deformities that give the disease its name. The World Health Organization recommends repeated rounds of mass drug administration, in which entire eligible populations receive antiparasitic medication regardless of infection status, as the cornerstone of global elimination efforts. Samoa, which has battled persistent filarial transmission for decades, deployed triple-drug therapy combining ivermectin, diethylcarbamazine and albendazole in 2018 and again in 2023, making it one of the few countries with two rounds of this intensified regimen.

The research team, led by Helen J. Mayfield of Australian National University and colleagues, designed a study to answer a deceptively simple question: did the second round of triple-drug treatment actually push transmission down? To find out, they conducted household surveys in eight primary sampling units at three time points. The first survey ran six to nine months after the 2018 campaign, the second came four and a half years later in 2023, and the third took place ten months after the 2023 treatment round. Participants aged five and older from randomly selected households were tested for circulating filarial antigen, a marker of adult worm infection, and for microfilariae, the microscopic offspring of adult worms that circulate in the blood and are the form mosquitoes pick up when they bite.

The human data told a sobering story. Antigen prevalence barely moved across the entire study period, sitting at 9.8 percent in 2019, 9.9 percent in 2023 and 10.3 percent in 2024. Statistical comparison of the 2024 and 2023 results confirmed the flat trend, with an odds ratio of 1.0 for antigen positivity, meaning no detectable decrease. Microfilariae prevalence, a more direct marker of active transmission potential, showed a suggestive but statistically uncertain decline, falling from 5.1 percent in 2023 to 3.1 percent in 2024, with an odds ratio of 0.6 whose confidence interval crossed the threshold of significance.

The mosquito data, however, revealed something the blood tests could not. The team deployed BG-Sentinel traps at participating households, sorted captured mosquitoes into species-specific pools, and screened them for filarial DNA using quantitative polymerase chain reaction, a technique known as molecular xenomonitoring. This approach detects parasite genetic material inside the insects themselves, providing a direct readout of how much transmission is actually occurring in the environment. After the 2023 treatment round, the prevalence of qPCR-positive mosquitoes dropped significantly, with an odds ratio of 0.4, meaning positive pools were roughly 60 percent less common than before the campaign.

Looking across the full five-year window from 2019 to 2024, the mosquito-based indicators showed sustained improvement for the species that matters most. Samoa’s filariasis problem is driven largely by Aedes polynesiensis, a day-biting mosquito with peculiar feeding habits that make standard interventions less effective. Prevalence of qPCR-positive Aedes species overall declined with an odds ratio of 0.5, and for Aedes polynesiensis specifically the odds ratio was 0.4, both indicating meaningful reductions over the study period.

The divergence between human and mosquito indicators is the study’s most consequential finding. Antigenemia reflects the presence of adult worms, which can survive for five years or more inside the human body even when treatment has sterilized them. This means antigen prevalence is a lagging indicator, slow to respond to successful interventions, and it may substantially overestimate ongoing transmission in the years immediately after a drug campaign. Microfilariae levels respond faster because the drugs rapidly clear the blood-stage parasites, but human surveys are expensive, logistically demanding and subject to participation bias.

Molecular xenomonitoring sidesteps several of these problems. Mosquitoes sample the transmission process itself, they can be collected in large numbers without requiring individual medical consent, and parasite DNA in mosquitoes reflects recent infections rather than long-lived adult worms. The Samoa results suggest that the 2023 triple-drug round did suppress transmission, as the mosquito data show, even while human antigen levels remained stubbornly unchanged. Had the program relied solely on antigen surveys, officials might have concluded the campaign had failed entirely, potentially triggering unnecessary additional rounds of drug distribution or misdirected resources.

These findings carry weight well beyond Samoa. The Global Programme to Eliminate Lymphatic Filariasis has set 2030 as its target date, and dozens of countries remain in the difficult endgame phase where transmission persists despite repeated treatment. Triple-drug therapy, which adds ivermectin to the traditional two-drug combination, was rolled out precisely because it clears microfilariae more completely and for longer than the standard regimen. Yet Samoa’s experience demonstrates that even this intensified approach, delivered twice with a five-year gap, could not fully interrupt transmission in a setting where the primary vector is unusually efficient at maintaining the parasite.

The authors conclude that mosquito-based indicators can provide a more sensitive measure of intervention impact in the immediate post-treatment period and should complement human serological surveillance for long-term monitoring. As elimination programs worldwide approach the finish line, the Samoa study offers a methodological lesson as much as an epidemiological one: choosing the right yardstick may determine whether hard-won progress is recognized, sustained and ultimately converted into elimination, or dismissed as failure by metrics that cannot yet see the difference.

Subject of Research: Impact of triple-drug mass drug administration on lymphatic filariasis transmission indicators in Samoa

Article Title: Evaluating the impact of triple-drug mass drug administration using human and mosquito-based indicators of lymphatic filariasis in Samoa, 2019 – 2024

Article References: Mayfield, H. J., McLure, A., Rigby, L., McPherson, B., Bradbury, R., Hedtke, S. M., Izuagbe, R., Kizu, J., MacKenzie, D., Panahi, E., Martin, B. M., Sartorius, B., Seeler, A., Ward, S., Thomsen, R., Viali, S., Graves, P. M., & Lau, C. L. (2026). Evaluating the impact of triple-drug mass drug administration using human and mosquito-based indicators of lymphatic filariasis in Samoa, 2019 – 2024. PLOS Neglected Tropical Diseases, 20(10), e0013895. https://doi.org/10.1371/journal.pntd.0013895

Image Credits: AI Generated

DOI: 10.1371/journal.pntd.0013895

Keywords: lymphatic filariasis, mass drug administration, Samoa, molecular xenomonitoring, Aedes polynesiensis, triple-drug therapy, neglected tropical diseases, microfilariae, filarial antigen, qPCR, mosquito surveillance, transmission elimination

The biological rationale for targeting Wolbachia is well established. These intracellular alpha-proteobacteria are not passive passengers; they are essential partners without which filarial nematodes cannot develop normally, reproduce, or remain viable over the long term. Depleting Wolbachia with tetracycline-class antibiotics such as doxycycline therefore undermines the worm itself, sterilizing adult females, shortening adult lifespan, and reducing the inflammatory pathology associated with dead and dying parasites. Because of these effects, veterinary guidelines commonly recommend doxycycline as an adjunct to melarsomine adulticide treatment and as the central component of slower, less intensive protocols for dogs that cannot tolerate adulticide therapy. The assumption underlying these recommendations is that an adequate doxycycline course reliably drives Wolbachia burdens down to undetectable levels, at least within the circulating microfilariae that are easiest to sample and quantify.

To test that assumption quantitatively, the researchers enrolled microfilaremic, heartworm-positive dogs identified in municipalities within the target areas of Rio de Janeiro State. Owners agreed to blood draws on day 0 and again on days 60 and 90, with a five-day window around each scheduled time point, and to administer doxycycline at 10 milligrams per kilogram twice daily for 28 days. Weekly telephone follow-up calls were used to help ensure that owners maintained the dosing schedule, an important consideration in any field study where incomplete compliance could confound the results. Critically, none of the enrolled dogs received any macrocyclic lactone, the class of preventive drugs that includes ivermectin, milbemycin, and moxidectin, at any point during the study. This design choice isolated the effect of doxycycline alone, which is precisely the scenario about which the least controlled field data exist.

The analytical approach combined classical parasitology with modern molecular quantification. On each experimental day, blood samples were subjected to the modified Knott’s test, the long-standing gold-standard technique for detecting and counting microfilariae, the larval offspring of adult female worms that circulate in the bloodstream. A portion of each sample was retained and frozen at minus 20 degrees Celsius for archival purposes, while the remainder was submitted for digital PCR, a technology that partitions each sample into thousands of microscopic reactions and counts target molecules individually. Digital PCR offers an advantage over conventional quantitative PCR in that it provides absolute counts of DNA copies without the need for standard curves, making it well suited to tracking changes in the ratio of Wolbachia DNA to D. immitis DNA within the same blood sample over time.

Thirty-one microfilaremic dogs completed the study, and 27 of them remained microfilaremic throughout the entire observation period. That persistence of circulating larvae in the vast majority of animals is itself noteworthy, because it confirms that doxycycline monotherapy, at least over a 90-day horizon, does not clear microfilaremia in most naturally infected dogs. The more striking molecular result concerned the endosymbiont. By day 90, Wolbachia had been cleared to undetectable levels in 25 of the 31 dogs, demonstrating that the 10 milligrams per kilogram twice-daily dose was fully effective in those cases and that the treatment protocol, as delivered, was capable of eliminating the symbiont from the circulating parasite population in most animals.

But six dogs told a different story. In these animals, digital PCR remained positive for Wolbachia DNA at the quantitative assessment, indicating that the endosymbiont’s genetic material persisted in the bloodstream months after the antibiotic course had ended. The proportions of Wolbachia relative to D. immitis DNA on days 60 and 90 were significantly lower than on day 0, with a p-value below 0.0001, confirming that the treatment did produce a dramatic overall reduction in the symbiont burden even in these persistent cases. When the researchers compared the day 60 and day 90 proportions directly, however, the difference was not statistically significant, with a p-value of 0.3127. In other words, between day 60 and day 90 the relative Wolbachia burden in the persistent dogs plateaued rather than continuing to decline, suggesting that whatever residual signal remained was not being progressively eliminated during the final month of observation.

The authors are careful about interpretation, and their caution is instructive. They note that the data may reflect the absence of macrocyclic lactone use in the cohort, since these preventive drugs kill microfilariae directly and would be expected to remove the larval population in which residual Wolbachia DNA might reside. Alternatively, dogs carrying higher adult worm burdens might simply harbor more symbiont-containing material than a standard doxycycline course can fully deplete. Yet the team explicitly acknowledges that it is not possible to confidently conclude that these factors entirely underpin the observations. The residual DNA signal could represent dead or dying bacteria whose genetic material has not yet been cleared from host tissues, or it could indicate genuinely surviving Wolbachia in a subset of worms or in a subpopulation of the symbiont itself. Distinguishing between these possibilities matters enormously, because DNA persistence from dead organisms is biologically benign, whereas surviving symbionts could repopulate their hosts once antibiotic pressure is removed.

This ambiguity leads directly to the study’s most important recommendation: further research should investigate whether the persistence is related to a lack of efficacy of doxycycline against certain Wolbachia subpopulations or to other, still unidentified factors. The idea of resistant or tolerant symbiont subpopulations is not far-fetched. Bacteria exposed to bacteriostatic drugs such as tetracyclines can enter low-metabolic states that permit survival, and genetic variation among Wolbachia strains infecting different worm individuals, or even different tissues within a single worm, could produce heterogeneous drug susceptibility. If a subpopulation of Wolbachia can withstand a full standard course of doxycycline, the implications extend beyond this single cohort, potentially affecting the reliability of doxycycline-based protocols in regions where such regimens are the only practical option for infected dogs.

For practicing veterinarians and pet owners, the study’s findings should be read as a call for measured reevaluation rather than alarm. The treatment was demonstrably effective in the majority of dogs, and even in the six persistent animals the symbiont burden fell dramatically and remained suppressed. What the study challenges is the assumption that a standard doxycycline course uniformly and permanently eliminates Wolbachia from every treated animal, particularly when no macrocyclic lactone is administered concurrently. It also highlights the value of digital PCR as a surveillance tool, since conventional microscopy of microfilariae would have revealed nothing about the symbiont status of these animals. As heartworm-endemic regions expand and drug-resistant parasite populations emerge, understanding the durability of the doxycycline-Wolbachia axis becomes increasingly consequential. The Rio de Janeiro cohort, small as it is, provides a quantitative baseline for that conversation and a clear agenda for the studies that must follow.

Subject of Research: Persistence of Wolbachia endosymbiont DNA in heartworm-infected dogs after doxycycline-only treatment

Article Title: Persistence of Wolbachia DNA in Dirofilaria immitis-infected canines after doxycycline-only treatment in Rio de Janeiro State, Brazil

Article References: Carithers, D., Alberigi, B., Scott, F., Mendes-de-Almeida, F., Borges, D., Labarthe, N., Brandão, Y., Cunha, R. S., de Souza Ramos, E. A., Molento, M., Yoon, S., McCall, J., & Harrington, J. (2026). Persistence of Wolbachia DNA in Dirofilaria immitis-infected canines after doxycycline-only treatment in Rio de Janeiro State, Brazil. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07621-9

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07621-9

Keywords: Wolbachia, Dirofilaria immitis, heartworm, doxycycline, dogs, digital PCR, microfilariae, Rio de Janeiro, veterinary parasitology, macrocyclic lactones, endosymbiont, Parasites & Vectors

The story begins with a sick cat. The animal presented with a subcutaneous nodule, a lump under the skin, and a blood test revealed an extraordinarily high level of circulating microfilariae, the larval stage of filarial worms, at 36,907 microfilariae per millilitre of blood. Surgeons removed a single adult male nematode from the nodule, and that worm, together with the larvae swimming in the cat’s bloodstream, became the basis for a combined morphological and genetic investigation. The case is notable because Dirofilaria infections are usually associated with dogs, and the role of cats or other non-canid animals as reservoir hosts for these parasites has remained uncertain.

Filarial nematodes of the genus Dirofilaria are best known through Dirofilaria immitis, the canine heartworm, but several other species infect the tissue under the skin rather than the heart. Dirofilaria repens, long recognised in dogs across Europe, Asia and Africa, is a well-documented zoonosis, meaning it can also infect humans, typically producing migrating nodules under the skin. More recently, researchers described Dirofilaria asiatica, a newly recognised zoonotic filaria of dogs in Asia, first characterised from specimens collected in Sri Lanka. However, uncertainty has surrounded D. asiatica from the start: scientists have debated whether it truly represents a single species or a species complex, and whether animals other than dogs might harbour it.

To identify the Hong Kong worm, the team took a two-pronged approach. First, they examined the adult male worm morphologically and morphometrically, measuring the anatomical features that parasitologists use to distinguish closely related Dirofilaria species. Second, they turned to genetics, sequencing the whole mitochondrial genome from the microfilariae found in the cat’s blood, and obtaining partial sequences of two mitochondrial markers, the cytochrome c oxidase subunit 1 gene, known as cox1, and the 12S mitochondrial ribosomal RNA gene, from the adult worm itself. Mitochondrial genomes are workhorses of parasite taxonomy because they evolve quickly enough to distinguish closely related species while being easy to recover from small amounts of material.

The qualitative morphology of the adult male proved frustratingly ambiguous. Its features were congruent with the original descriptions of three different species: Dirofilaria minor, described by Sandground in 1932 from leopard cats, Felis bengalensis, in Vietnam; D. repens, described from dogs in Italy in 1911; and D. asiatica, described from dogs in Sri Lanka. These species are so similar in their gross anatomy that a single specimen cannot be assigned to one of them by appearance alone. The quantitative measurements, however, offered a sharper clue. The length and ratio of the spicules, the needle-like mating structures of male nematodes, and the number of pre-anal papillae, small sensory structures arranged in front of the anus, aligned most closely with D. minor.

The microfilariae told a complementary story. When stained with methylene blue and measured, the larvae from the cat’s blood overlapped morphometrically with values reported for both D. repens and D. asiatica, again failing to single out one species definitively. This overlap illustrates a persistent problem in filarial diagnostics: the larval stages of these parasites are morphologically conservative, and even careful measurements of stained specimens can straddle the boundaries between species. It is precisely this kind of ambiguity that has fuelled the debate over whether the Asian parasites represent one species, several species, or a species complex in the making.

Genetics broke the tie. Phylogenetic analysis of the whole mitochondrial genome recovered from the microfilariae, together with analyses of the 12S rRNA and cox1 fragments from the adult worm, placed the Hong Kong parasite within a well-supported clade that included D. asiatica from dogs in Sri Lanka and a parasite known in the literature as Dirofilaria sp. “hongkongensis”, recovered from a human infection in India. The genetic evidence was therefore clear: the worm in the cat was D. asiatica, regardless of what its anatomy suggested. The convergence of molecular and morphological data on different answers is itself informative, revealing that the current species boundaries in this group do not map neatly onto either morphology or genetics alone.

Here lies the twist that gives the study its wider significance. The adult worm was genetically D. asiatica, yet morphologically indistinguishable from the original description of D. minor, a species named more than ninety years ago from a wild felid in Vietnam. The authors argue that the parasite long referred to as Dirofilaria sp. “hongkongensis”, and recently formally described as D. asiatica, may in fact be D. minor. Under the rules of zoological nomenclature, the oldest available name takes priority, so if the hypothesis is confirmed, D. asiatica would become a junior synonym of D. minor and the older name would prevail. Resolving the question requires additional specimens from Vietnam, the type locality of D. minor, so that morphology and genetics can be compared directly against the species as originally defined.

Beyond the taxonomic debate, the case carries practical implications for medicine and public health in Asia. D. asiatica is recognised as a zoonotic parasite, and the discovery of a genetically confirmed infection in a cat with an enormous microfilaremia demonstrates that domestic felids can sustain patent infections, producing larval stages in their blood that mosquitoes can pick up and transmit. Cats, in other words, may serve as reservoir hosts capable of maintaining and spreading the parasite in urban environments. The earlier detection of the same lineage in a human patient in India underscores that the parasite already crosses species barriers into people, usually manifesting as subcutaneous nodules that can be mistaken for tumours or other conditions.

The Hong Kong study also highlights the value of combining classical parasitology with modern genomics. Morphological examination of a single worm produced measurements pointing to a ninety-year-old name, while mitochondrial genome sequencing anchored the specimen firmly within a clade of Asian parasites linked to both dog and human infections. Neither approach alone could have resolved the identity of the parasite, and neither alone could have exposed the mismatch between the two lines of evidence. As the authors note, further detailed morphological and genetic studies using additional specimens, particularly from Vietnam, are needed to confirm whether D. asiatica and D. minor are one and the same. Until then, a worm from a Hong Kong cat stands as a reminder that some of the most consequential discoveries in parasitology begin with a routine clinical case, and that the names scientists give to parasites may conceal as much as they reveal about their origins, hosts and potential to cause human disease.

Subject of Research: Taxonomic identification of a zoonotic Dirofilaria nematode infecting a domestic cat in Hong Kong

Article Title: Unlocking the identity of a case of feline subcutaneous dirofilariasis in Hong Kong

Article References: Frias, L., Zhou, Y., Almendros, A., Li, R., & Traub, R. J. (2026). Unlocking the identity of a case of feline subcutaneous dirofilariasis in Hong Kong. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07677-7

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07677-7

Keywords: Dirofilaria asiatica, Dirofilaria minor, filarial nematodes, cats, zoonosis, Hong Kong, mitochondrial genome, phylogeny, morphology, parasite taxonomy, microfilariae, reservoir hosts